Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 6, 2025Diabetes/Metabolism Research and Reviews

Finerenone in Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Efficacy and Safety

View Full Paper
Ask AI
Bookmark
Share

Authors

YHYonglu HuCLChengqian LiSLShufa Li

Discussion

Loading...

Member takes

Overview

Comprehensive review reveals finerenone's efficacy in CKD, highlighting its safety profile and implications for treatment.

Key Points

  • Main finding indicates finerenone's potential in chronic kidney disease via mineralocorticoid receptor antagonism.
  • Key evidence shows finerenone reduces hyperkalemia risk compared to first- and second-generation MRAs.
  • Approach includes reviewing clinical applications of finerenone alongside sodium-glucose cotransporter-2 inhibitors.
  • Significance lies in its cardiorenal protective effects, suggesting new treatment combinations for improved outcomes.

Cite This Study

Hu et al. (2025) studied this question.

synapsesocial.com/papers/689a0fa0e6551bb0af8d18a4https://doi.org/10.1002/dmrr.70075
View Full Paper
Ask AI
Bookmark
Share